In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Preparing For The Zero Moment Of Truth: Managing Early Awareness In Rare Disease Drug Commercialization

Executive Summary

Awareness of new rare disease drugs develops much earlier than traditional therapies. Biopharma companies need to provide and actively manage information to the many stakeholders interested in new products’ progress and potential.


Related Content

Orphans Should Live Alone
The Birth Of An Orphan Biosimilar Market


Related Companies